P143 IMPACT OF THE NUMBERS OF COMPONENTS OF CARDIO-RENO-METABOLIC SYNDROME PLUS OBESITY ON PATIENTS WITH HEART FAILURE WITH PRESERVED EJECTION FRACTION: A SUB-ANALYSIS OF THE ARFEY-PRESER REGISTRY

Background and Objectives: The primary objective was to evaluate whether the presence of combined cardio-reno-metabolic syndrome and obesity (CRM+O) in patients with heart failure with preserve ejection fraction (HFpEF) had a greater impact on cardiovascular disease (CVD). Materials and Methods: This prospective, multicentre observational registry enrolled outpatients or those discharged from hospitals, with prior informed consent. The study spanned from December 2022 to February 2024. Inclusion criteria were: 1) presence of current signs and symptoms of heart failure and LVEF ≥50%, 2) structural heart disease, 3) elevated natriuretic peptides. CRM+O was defined according with the number of components defined as: coronary artery disease (myocardial infarction, revascularization or ≥ 50% in one coronary artery), chronic renal disease (TFG ≤60 ml/min/1.72m2), diabetes mellitus and obesity (BMI ≥30 kg/m2) Results: This sub study included 388 patients, and at least one component of CRM+O was identified in 333 (86.9%), with 1, 2, 3 and 4 components in 23.8%, 30.8%, 27.7% and 4.7%. Demographics and clinical profile comparison is presented in Table 1. With the increasing number of components of CRM+O there was a higher proportion of women, sedentarism (p=0.001), smoking (p<0.001), OSA (p<0.001), hypothyroidism (p=0.010), coronary artery disease on angiography (p<0.001) and peripheral artery disease (p=0.010). Conclusions In patients with HFpEF, a high prevalence of combined components of CRM+O was observed, and 1 out of 3 presented at least three of them. A positive correlation between increasing in the severity and comorbidities was observed, except by inverse relationship with atrial fibrillation. These findings support the interaction among HFpEF and CRM+O syndrome and suggest the need of comprehensive, multidisciplinary management.

Authors

Publication Details

Journal
Journal of Hypertension
Published
2024-09-01
DOI
https://doi.org/10.1097/01.hjh.0001063444.42812.2b
Primary Topic
Diet and metabolism studies
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

P143 IMPACT OF THE NUMBERS OF COMPONENTS OF CARDIO-RENO-METABOLIC SYNDROME PLUS OBESITY ON PATIENTS WITH HEART FAILURE WITH PRESERVED EJECTION FRACTION: A SUB-ANALYSIS OF THE ARFEY-PRESER REGISTRY

David Huerta Hernández, Gianluca Castiello, Guillermo Cursack, Daniela García Brasca et al.
Journal of Hypertension
Diet and metabolism studies
article

P143 IMPACT OF THE NUMBERS OF COMPONENTS OF CARDIO-RENO-METABOLIC SYNDROME PLUS OBESITY ON PATIENTS WITH HEART FAILURE WITH PRESERVED EJECTION FRACTION: A SUB-ANALYSIS OF THE ARFEY-PRESER REGISTRY

David Huerta Hernández, Gianluca Castiello, Guillermo Cursack, Daniela García Brasca, Diego Picchio, Nicolás Renna, Diego Echazarreta, Juan Pablo Escalante, V Franchi, Eduardo Perna, María Lorena Coronel, V Botelli Dagun, C Mandredi, Cecilia Morris, JP Cimbaro Canella
article en

Abstract

Background and Objectives: The primary objective was to evaluate whether the presence of combined cardio-reno-metabolic syndrome and obesity (CRM+O) in patients with heart failure with preserve ejection fraction (HFpEF) had a greater impact on cardiovascular disease (CVD). Materials and Methods: This prospective, multicentre observational registry enrolled outpatients or those discharged from hospitals, with prior informed consent. The study spanned from December 2022 to February 2024. Inclusion criteria were: 1) presence of current signs and symptoms of heart failure and LVEF ≥50%, 2) structural heart disease, 3) elevated natriuretic peptides. CRM+O was defined according with the number of components defined as: coronary artery disease (myocardial infarction, revascularization or ≥ 50% in one coronary artery), chronic renal disease (TFG ≤60 ml/min/1.72m2), diabetes mellitus and obesity (BMI ≥30 kg/m2) Results: This sub study included 388 patients, and at least one component of CRM+O was identified in 333 (86.9%), with 1, 2, 3 and 4 components in 23.8%, 30.8%, 27.7% and 4.7%. Demographics and clinical profile comparison is presented in Table 1. With the increasing number of components of CRM+O there was a higher proportion of women, sedentarism (p=0.001), smoking (p<0.001), OSA (p<0.001), hypothyroidism (p=0.010), coronary artery disease on angiography (p<0.001) and peripheral artery disease (p=0.010). Conclusions In patients with HFpEF, a high prevalence of combined components of CRM+O was observed, and 1 out of 3 presented at least three of them. A positive correlation between increasing in the severity and comorbidities was observed, except by inverse relationship with atrial fibrillation. These findings support the interaction among HFpEF and CRM+O syndrome and suggest the need of comprehensive, multidisciplinary management.

Journal of HypertensionVol. 42(Suppl 3)
Openalex Percentile: Top 79%
Diet and metabolism studies
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.